TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/03 | 2022/03 | 2021/03 |
Turnover |
3,885
|
3,980
|
4,691 |
Financial expenses |
14
|
70
|
55 |
Earnings before taxes |
177
|
142
|
223 |
EBITDA |
191
|
146
|
237 |
Total assets |
4,975
|
4,374
|
4,253 |
Current assets |
4,975
|
4,374
|
4,253 |
Current liabilities |
1,621
|
1,051
|
994 |
Equity capital |
3,354
|
3,324
|
3,259 |
- share capital |
22
![]() |
22
![]() |
22 |
Employees (average) |
16
|
18
|
19 |
Financial ratios
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Solvency |
67.4%
|
76.0%
|
76.6% |
Turnover per employee |
243
|
221
|
247 |
Profit as a percentage of turnover |
4.6%
|
3.6%
|
4.8% |
Return on assets (ROA) |
3.8%
|
4.8%
|
6.5% |
Current ratio |
306.9%
|
416.2%
|
427.9% |
Return on equity (ROE) |
5.3%
|
4.3%
|
6.8% |
Change turnover |
235
|
-665
|
-1,629 |
Change turnover % |
6%
|
-14%
|
-26% |
Chg. No. of employees |
-2
|
-1
![]() |
-1 |
Chg. No. of employees % |
-11%
|
-5%
![]() |
-5% |
Total value of public sale
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.